← Screener

EWEdwards Lifesciences

Health care · Medical Devices · NYSE

Compare with peers → Embed

Filings with the SEC since Apr 26, 2019

1,009 filings, 8 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 25, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Nov 4, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Nov 4, 2026

8-K: Quarterly results

Filed in the last 30 days

of 1,009 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 25 events

Nov 4, 20268-K Quarterly results 8-K item 2.02
Nov 4, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Aug 28, 20268-K Director or officer change 8-K item 5.02
Aug 4, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jul 23, 20268-K Quarterly results 8-K item 2.02
May 8, 20268-K Director or officer change, Shareholder vote results 8-K items 5.02, 5.07
May 6, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
May 4, 2026Officer CFO change On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B.
Apr 23, 20268-K Quarterly results 8-K item 2.02
Feb 25, 202610-K Annual report (10-K) period ended Dec 31, 2025
Feb 10, 20268-K Quarterly results 8-K item 2.02
Jan 12, 20268-K Regulation FD disclosure 8-K item 7.01
Nov 5, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 30, 2025Officer CFO change The Corporation is initiating a selection process to appoint a new Chief Financial Officer.
Oct 30, 20258-K Quarterly results 8-K item 2.02
Aug 19, 20258-K Other events 8-K item 8.01
Aug 6, 20258-K Regulation FD disclosure 8-K item 7.01
Aug 6, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 25, 20258-K Director or officer change 8-K item 5.02
Jul 24, 20258-K Quarterly results 8-K item 2.02
May 8, 20258-K Director or officer change, Shareholder vote results 8-K items 5.02, 5.07
May 6, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 23, 20258-K Quarterly results 8-K item 2.02
Feb 28, 202510-K Annual report (10-K) period ended Dec 31, 2024
Feb 11, 20258-K Quarterly results 8-K item 2.02

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1009 Annual & quarterly 31 Current reports (8-K) 59 Insiders 837 Proxy & votes 25 Big owners (13D/13G) 17 Shares & debt offered 9 SEC letters 3 Other 28

Filed	Form	What it is	Period
Mar 26, 2026	DEFA14A	Extra proxy material		all files
Mar 26, 2026	DEFA14A	Extra proxy material		all files
Mar 26, 2026	DEF 14A	Proxy statement	May 7, 2026	all files
Apr 14, 2025	DEFA14A	Extra proxy material		all files
Mar 26, 2025	DEFA14A	Extra proxy material		all files
Mar 26, 2025	DEFA14A	Extra proxy material		all files
Mar 26, 2025	DEF 14A	Proxy statement	Dec 31, 2024	all files
Mar 26, 2024	DEFA14A	Extra proxy material		all files
Mar 26, 2024	DEFA14A	Extra proxy material		all files
Mar 26, 2024	DEF 14A	Proxy statement	Dec 31, 2023	all files
Mar 28, 2023	DEFA14A	Extra proxy material		all files
Mar 28, 2023	DEFA14A	Extra proxy material		all files
Mar 28, 2023	DEF 14A	Proxy statement		all files
Mar 14, 2023	PRE 14A			all files
Mar 22, 2022	DEFA14A	Extra proxy material		all files
Mar 22, 2022	DEFA14A	Extra proxy material		all files
Mar 22, 2022	DEF 14A	Proxy statement	May 3, 2022	all files
Mar 23, 2021	DEFA14A	Extra proxy material		all files
Mar 23, 2021	DEFA14A	Extra proxy material		all files
Mar 23, 2021	DEF 14A	Proxy statement	May 4, 2021	all files
Apr 13, 2020	DEFA14A	Extra proxy material		all files
Mar 25, 2020	DEFA14A	Extra proxy material		all files
Mar 25, 2020	DEFA14A	Extra proxy material		all files
Mar 25, 2020	DEF 14A	Proxy statement	May 7, 2020	all files
Mar 9, 2020	PRE 14A		May 7, 2020	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →